Harmony L. Tyner

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 794 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · New England Journal of Medicine · 2021 · 525 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021

Ashley Fowlkes, Manjusha Gaglani, Kimberly Groover et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 313 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley Fowlkes, Sarang K. Yoon, Karen Lutrick et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 183 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · medRxiv · 2021 · 56 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17